An Evaluation of the Interactions of Antiestrogens with Pituitary and Striatal Dopamine Receptors

References

• Katzenellenbogen B. S., Miller M. A., Mullick A., Sheen Y. Y. Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites. Breast Cancer Res. and Treatment 1985; 5: 231–243
   PubMedGoogle Scholar
• Horwitz K. B., Mc W. L., Guire. Antiestrogens: Mechanisms of action and effects in breast cancer. Breast Cancer Advances in Research and Treatment, W. L. McGuire. Plenum Press, New York 1978; Vol. 2: 155–204
   Google Scholar
• Sutherland R. L., Foo M. S., Green M. D., Waybourne A. M., Krozowski Z. S. High affinity antiestrogen binding site distinct from the estrogen receptor. Nature 1980; 288: 273–275
   Google Scholar
• Sudo K. F., Monsma J., Jr., Katzenellenbogen B. S. Antiestrogen binding sites distinct from the estrogen receptor: Subcellular localization, ligand specificity and distribution in tissues of the rat. Endocrinology 1983; 112: 425–434
   PubMed Web of Science ®Google Scholar
• Hiemke C., Ghraf R. Interaction of non-steroidal antiestrogens with dopamine receptor binding. J. Steroid Biochem. 1984; 21: 663–667
   Google Scholar
• Seeman P. Brain dopamine receptors. Pharmacol. Rev. 1980; 32: 229–313
   PubMed Web of Science ®Google Scholar
• Barton M. D., Libonati M., Cohen P. J. The use of haloperidol for treatment of postoperative nausea and vomiting - A double blind placebo-controlled trial. Anesthesiology 1975; 42: 408–412
   Google Scholar
• Lieberman M. E., Jordan V. C., Fritsch M., Santos M. A., Gorski J. Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens invitro. J. Biol. Chem. 1983; 258: 4734–4740
   PubMed Web of Science ®Google Scholar
• Toney T. W., Katzenellenbogen B. S. Antiestrogen action in the medial basal hypothalamus and pituitary of immature female rats: Insights concerning relationships among estrogen, dopamine and prolactin. Endocrinology 1986; 119: 2661–2669
   PubMedGoogle Scholar
• Sheen Y. Y., Simpson D. M., Katzenellenbogen B. S. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: Studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor. Endocrinology 1985; 117: 561–564
   PubMedGoogle Scholar
• Cronin M. J., Weiner R. I. 3H-spiroperidol binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence. Endocrinology 1979; 104: 307–312
   PubMed Web of Science ®Google Scholar
• Pasqualini C., Veronique L., Abed A. E., Kerdelhue B. Anterior pituitary dopamine receptors during the rat estrous cycle. Neuroendocrinol. 1984; 38: 39–44
   Google Scholar
• Glowinski J., Iverson L. L. Regional studies of catecholamines in the rat brain-I: The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 1966; 13: 655–669
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 1949; 51: 660–672
   Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 1951; 258: 4741–4745
   Google Scholar
• Katzenellenbogen J. A., Heiman D. F., Carlson K. E., Lloyd J. E. In vivo and in vitro teroid receptor assays in the design of estrogen radiopharmaceuticals. Receptor-Binding Radiotracers, W. C. Eckelman. CRC Press, Boca Raton, Florida 1982; Vol. 1: 93–126
   Google Scholar
• Anderson J. N., Peck E. J., Clark J. H. Nuclear receptor-estrogen complex: Invivo and invitro binding of estra-diol and estriol as influenced by serum albumin. J. Steroid Biochem. 1974; 5: 103–107
   PubMedGoogle Scholar
• Levitzki A., Sevilia N., Atlas D., Steer M. L. Ligand specificity and characteristics of the β-adrenergic receptor in turkey erythrocyte plasma membranes. J. Mol. Biol. 1975; 97: 35–47
   Google Scholar
• Zaagsma J., Meems L., Boorsma M. β-adrenoreceptor studies. 4. Influence of albumin on invitro β-adrenoceptor blocking and antiarrhythmic properties of propanolol, pindolol, practolol and protoprolol. Nannyn-Schmiedeberg's. Arch. Pharmacol. 1977; 298: 29–36
   Google Scholar
• Adam H. K. A review of the pharmacokinetics and metabolism of “nolvadex” (tamoxifen). Non-Steroidal Antiestrogens, R. L. Sutherland, V. C. Jordan. Academic Press, Sydney 1981; 59–73
   Google Scholar
• Daniel C. P., Gaskell S. J., Bishop H., Nicholson R. I. Determination of tamoxifen and an hydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography-mass spectrometry. J. Endocrinol. 1979; 83: 401–408
   PubMed Web of Science ®Google Scholar
• Caron M. G., Beaulieu M., Raymone V., Gagne B., Drouin J., Lefkowitz R. J., Labrie F. Dopaminergic receptors in the anterior pituitary gland. J. Biol. Chem. 1978; 253: 2244–2253
   Google Scholar
• Cronin M. J., Koritnik D. R. Dopamine receptors of the monkey anterior pituitary in various endocrine states. Endocrinology 1983; 112: 618–623
   Google Scholar
• Schettini G., Cronin M. J., Mac R. M., Leod. Adenosine 3′-5′-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: Evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization. Endocrinology 1983; 112: 1801–1807
   PubMedGoogle Scholar